Correction to AstraZeneca Drug Trial Story
18 May 2016 - 8:38PM
Dow Jones News
AstraZeneca PLC's gastric cancer treatment trial missed its
targets. "AstrazZeneca Gastric Cancer Treatment Trial Misses
Targets," at 0631 GMT, misspelled AstraZeneca as AstrazZeneca in
the headline.
(END) Dow Jones Newswires
May 18, 2016 06:23 ET (10:23 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024